What is AngioDynamics?
Established in 1988 as a division of E-Z-EM, AngioDynamics has cultivated a legacy of innovation in the medical device industry. The company is dedicated to developing high-quality medical devices aimed at improving patient outcomes. With a robust global presence, AngioDynamics operates worldwide, leveraging strategic partnerships and an extensive distribution network to deliver its diverse product portfolio. Its commitment to advancing medical solutions has solidified its standing in key healthcare markets, contributing significantly to patient care on an international scale.
How much funding has AngioDynamics raised?
AngioDynamics has raised a total of $376.4M across 3 funding rounds:
Stock Offering
$21.4M
Debt
$250M
Debt
$105M
Stock Issuance/Offering (2004): $21.5M, investors not publicly disclosed
Debt (2016): $250M, investors not publicly disclosed
Debt (2022): $105M, investors not publicly disclosed
What's next for AngioDynamics?
The recent major strategic investment of $105M positions AngioDynamics for accelerated expansion and further innovation in its product lines. This capital infusion is expected to bolster the company's research and development efforts, potentially leading to new device introductions and enhancements to existing offerings. AngioDynamics' focus on improving patient outcomes, coupled with its established global footprint, suggests a strategic direction aimed at capturing greater market share and solidifying its role as a key partner within the medical community. The company's trajectory indicates a continued emphasis on strategic growth and operational excellence.
See full AngioDynamics company page
